To prevent the overexpression of osteoclasts in osteoporosis, the new target—RANK—and RANK/RANKL complex as well as progesterone receptor and their biological function should be addressed as a new aspect of prevention of women’s health disorders during their postmenopausal and hormone-depend time of life. Here, TNFRSF11A is linked to osteoporosis.